Professor Timothy O'Brien, Dean of the College of Medicine, Nursing, and Health Sciences at NUI Galway and consultant endocrinologist at Galway University Hospitals, has received the Mayo Clinic Distinguished Alumni Award. The award was established by the Mayo Clinic Board of Trustees in 1981 to acknowledge and show appreciation for exceptional contributions of Mayo Clinic alumni to the field of medicine.
Professor O’Brien is an internationally recognised clinician-scientist with expertise in regenerative medicine applied to the treatment of diabetes complications. He has influenced a generation of Irish clinicians and scientists. His ties to Mayo Clinic allow trainees from NUI Galway and Galway University Hospitals to spend time at Mayo Clinic and for the Mayo faculty to spend time in the university and hospital in Galway, ensuring that the Mayo Clinic ethos is evident on the wards, and in the clinics and laboratories, in Ireland. He is also a director of the Regenerative Medicine Institute at NUI Galway and is lead endocrinologist at Saolta University Health Care Group and co-director of CÚRAM, the SFI Centre for Research in Medical Devices at NUI Galway.
In addition to his administrative and leadership responsibilities, Professor O’Brien has a major teaching commitment to the School of Medicine at NUI Galway and was twice awarded the Pat McHugh Medal for Best Consultant Teacher. He maintains a busy clinical practice in general internal medicine, diabetes, endocrinology, and metabolism. He established a bariatric medicine clinic in Galway University Hospitals, one of only two such centres in Ireland.
Previously Professor O’Brien was an endocrinologist at Mayo Clinic in Rochester and an associate professor of medicine at Mayo Clinic College of Medicine and Science.
During his Mayo Foundation scholarship at the Gladstone Institute at the University of California, San Francisco, Professor O’Brien developed expertise in gene therapy. When he returned to Mayo Clinic, he established one of the first gene therapy laboratories at Mayo and published internationally recognised studies exploring the role of nitric oxide synthase in modulating the vascular endothelium. His major scientific contributions at NUI Galway have been delivering first-in-man studies of mesenchymal stem cell-derived regenerative medicine therapies for diabetes complications, including diabetic nephropathy and critical limb ischemia. He has coordinated two multinational consortia, REDDSTAR and NEPHSTROM, funded by the European Commission. Professor O’Brien has also contributed significantly to the local Galway economy through collaborations with medical device companies and startups as a result of his research activity.
Professor O’Brien is on the governing body of NUI Galway and executive management team of the Saolta University Health Care Group, one of six hospital groups in Ireland’s Health Service Executive. With these leadership roles, he has influenced and shaped the direction of higher education and health care sectors regionally and nationally. Under his leadership, the NUI Galway campus has been transformed with new buildings dedicated to biomedical science, medical education, clinical research, and stem cell manufacturing.
A native of Cork, Professor O’Brien received a PhD in medicine and a medical degree from University College Cork. He completed a postdoctoral fellowship as a Mayo Clinic Scholar at the Gladstone Institute of Cardiovascular Disease in San Francisco, and a fellowship in endocrinology and metabolism at Mayo Clinic School of Graduate Medical Education in Rochester. He completed internal medicine residency at Cork University Hospital in Ireland.
